Francesco Lanza (Ernesta Audisio, F Lanza)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 27

Top Topics

Acute Myeloid Leukemia

Stem Cell Transplantation

Peripheral Blood

Top Venues

American journal of hematology

Bone marrow transplantation

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Austin G Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, Saskia Langemeijer, Satheesh Chonat, Anil Tombak, Vladimir Hanes, Jia Cao, Mieke Jill Miller, Alexander Colbert, Benjamin Shander, Daniel T Mytych, Vincent Chow, Haby Henary
Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria. American journal of hematology (2024)
Serena Rocchi, Beatrice Anna Zannetti, Giovanni Marconi, Francesco Lanza
Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy. Cells 13 (10) (2024)
Chiara Ronchini, Federica Gigli, Martina Fontanini, Raffaella Furgi, Viviana Amato, Fabio Giglio, Giuliana Gregato, Francesco Bertolini, Michela Rondoni, Francesco Lanza, Atto Billio, Enrico Derenzini, Corrado Tarella, Pier Giuseppe Pelicci, Myriam Alcalay, Elisabetta Todisco
Identification of Novel Potential Predisposing Variants in Familial Acute Myeloid Leukemia. Cancer reports (Hoboken, N.J.) 7 (8) (2024)
Serena Rocchi, Beatrice Anna Zannetti, Giovanni Marconi, Francesco Lanza
Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy. Cells 13 (10) (2024)
Chiara Ronchini, Federica Gigli, Martina Fontanini, Raffaella Furgi, Viviana Amato, Fabio Giglio, Giuliana Gregato, Francesco Bertolini, Michela Rondoni, Francesco Lanza, Atto Billio, Enrico Derenzini, Corrado Tarella, Pier Giuseppe Pelicci, Myriam Alcalay, Elisabetta Todisco
Identification of Novel Potential Predisposing Variants in Familial Acute Myeloid Leukemia. Cancer reports (Hoboken, N.J.) 7 (8) (2024)
Serena Rocchi, Beatrice Anna Zannetti, Giovanni Marconi, Francesco Lanza
Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy. Cells 13 (10) (2024)
Francesco Lanza, Roberto De Giorgio, Giorgio Zavagli
The oldest case of lymphoma? Insights from a XIII century fresco. British journal of haematology (2023)
Francesco Lanza, Michela Rondoni, Beatrice Anna Zannetti
New Horizons in Immunology and Immunotherapy of Acute Leukemias and Related Disorders. Cancers 15 (9) (2023)
Enrico Maffini, Maud Ngoya, Jacques-Emmanuel Galimard, Samia Harbi, Nicolaus Kröger, Uwe Platzbecker, Henrik Sengeloev, Charles F Craddock, Victoria Potter, Goda Choi, Patrice Chevallier, Friedrich Stölzel, Eleni Tholouli, Johan A Maertens, Fabio Ciceri, Jan Cornelissen, Jaime Sanz Caballer, Alexandros Spirydonidis, Francesco Lanza, Arnon Nagler, Florent Malard
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone marrow transplantation (2023)
Francesco Lanza, Michela Rondoni, Beatrice Anna Zannetti
New Horizons in Immunology and Immunotherapy of Acute Leukemias and Related Disorders. Cancers 15 (9) (2023)
Jaime Sanz Caballer, Myriam Labopin, Thomas Pabst, Jurjen Versluis, Gwendolyn Van Gorkom, Ellen Meijer, Tobias Gedde-Dahl, Juan Montoro Gómez, William Arcese, José Antonio Pérez-Simón, Nicolaas Schaap, Johan Maertens, Radovan Vrhovac, Francesco Lanza, Norbert-Claude Gorin, Florent Malard, Fabio Ciceri
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation (2023)
Enrico Maffini, Myriam Labopin, Dietrich Wilhelm Beelen, Nicolaus M Kröger, Mutlu Arat, Keith M O Wilson, Jacques-Olivier Bay, Arnold Ganser, Hans Martin, Jakob Passweg, Panagiotis D Kottaridis, Ibrahim Yakoub Agha, Rocio Parody Porras, Eva Maria Wagner, Aleksandra Holowiecka, Francesco Lanza, Arnon Nagler, Florent Malard
Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT). Bone marrow transplantation 57 (10) (2022)
Francesco Lanza, Federica Monaco, Fabio Ciceri, Roberto Cairoli, Maria Vittoria Sacchi, Anna Guidetti, Monia Marchetti, Massimo Massaia, Luca Arcaini, Mauro Krampera, Sara Mohamed, Filippo Gherlinzoni, Cristina Mecucci, Massimo Gentile, Ilaria Romano, Adriano Venditti, Marco Ruggeri, Dario Ferrero, Elisa Coviello, Elisabetta Fabbri, Paolo Corradini, Francesco Passamonti
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study. Hematological oncology (2022)
Patrizia Zappasodi, Chiara Cattaneo, Virginia Valeria Ferretti, Roberto Mina, Andrés José María Ferreri, Francesco Merli, Margherita Oberti, Mauro Krampera, Alessandra Romano, Caterina Zerbi, Jacqueline Ferrari, Michele Cavo, Marco Salvini, Lorenza Bertù, Nicola Stefano Fracchiolla, Francesco Marchesi, Massimo Massaia, Vincenzo Marasco, Roberto Cairoli, Anna Maria Scattolin, Alessandro Maria Maria Vannucchi, Carlo Gambacorti-Passerini, Pellegrino Musto, Filippo Gherlinzoni, Antonio Cuneo, Antonello Pinto, Livio Trentin, Monica Bocchia, Sara Galimberti, Elisa Coviello, Maria Chiara Tisi, Alessandro Morotti, Brunangelo Falini, Mauro Turrini, Agostino Tafuri, Atto Billio, Massimo Gentile, Roberto Massimo Lemoli, Adriano Venditti, Matteo Giovanni Della Porta, Francesco Lanza, Luigi Rigacci, Patrizia Tosi, Sara Mohamed, Alessandro Corso, Mario Luppi, Nicola Giuliani, Alessandro Busca, Livio Pagano, Raffaele Bruno, Paolo Antonio Grossi, Paolo Corradini, Francesco Passamonti, Luca Arcaini, null null
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV. Hematological oncology (2022)
Carlo Lazzaro, Luca Castagna, Francesco Lanza, Daniele Laszlo, Giuseppe Milone, Luca Pierelli, Riccardo Saccardi
Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis. Bone marrow transplantation 56 (8) (2021)
Francesco Passamonti, Alessandra Romano, Marco Salvini, Francesco Merli, Matteo G Della Porta, Riccardo Bruna, Elisa Coviello, Ilaria Romano, Roberto Cairoli, Roberto Lemoli, Francesca Farina, Adriano Venditti, Alessandro Busca, Marco Ladetto, Massimo Massaia, Antonello Pinto, Luca Arcaini, Agostino Tafuri, Francesco Marchesi, Nicola Fracchiolla, Monica Bocchia, Daniele Armiento, Anna Candoni, Mauro Krampera, Mario Luppi, Valeria Cardinali, Sara Galimberti, Chiara Cattaneo, Elettra Ortu La Barbera, Roberto Mina, Francesco Lanza, Giuseppe Visani, Pellegrino Musto, Luigi Petrucci, Francesco Zaja, Paolo A Grossi, Lorenza Bertù, Livio Pagano, Paolo Corradini, null null
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. British journal of haematology 195 (3) (2021)
Wilma Barcellini, Bruno Fattizzo, Juri Alessandro Giannotta, Luisa Quattrocchi, Semra Aydin, Federica Barone, Cecilia Carbone, Fabrizio Pomponi, Elisabetta Metafuni, Eloise Beggiato, Simona Sica, Eros Di Bona, Francesco Lanza, Rosario Notaro, Anna P Iori
COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey. British journal of haematology 194 (5) (2021)
Michele Gottardi, Francesco Lanza, Alessandra Sperotto, Davide Nappi, Andrea Ghelli Luserna di Rorà, Antonella Padella, Marianna Norata, Maria Benedetta Giannini, Gerardo Musuraca, Francesco Lanza, Claudio Cerchione, Giovanni Martinelli
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin. Cancers 13 (18) (2021)
Maria Chiara Fontana, Jacopo Nanni, Andrea Ghelli Luserna di Rorà, Elisabetta Petracci, Antonella Padella, Martina Ghetti, Anna Ferrari, Giovanni Marconi, Simona Soverini, Ilaria Iacobucci, Cristina Papayannidis, Antonio Curti, Francesco Lanza, Maria Benedetta Giannini, Giovanni Martinelli, Francesco Lanza, Michele Cavo, Giovanni Martinelli, Giorgia Simonetti
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a. Biomedicines 9 (4) (2021)
Francesco Lanza, Ali Bazarbachi
Targeted Therapies and Druggable Genetic Anomalies in Acute Myeloid Leukemia: From Diagnostic Tools to Therapeutic Interventions. Cancers 13 (18) (2021)
Beatrice Anna Zannetti, Angelo Corso Faini, Evita Massari, Massimo Geuna, Enrico Maffini, Giovanni Poletti, Claudio Cerchione, Giovanni Martinelli, Fabio Malavasi, Francesco Lanza
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model. Cells 9 (12) (2020)
Enrico Maffini, Myriam Labopin, Didier Blaise, Fabio Ciceri, Zafer Gülbas, Eric Deconinck, Veronique Leblond, Patrick Chevallier, Gerard Sociè, Mercedes C Araujo, Yener Koc, Bipin N Savani, Norbert-Claude Gorin, Francesco Lanza, Arnon Nagler, Mohamad Mohty
CD34+ cell dose effects on clinical outcomes after T-cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT). American journal of hematology 95 (8) (2020)
Alberto L Horenstein, Angelo C Faini, Fabio Morandi, Cristiano Bracci, Francesco Lanza, Nicola Giuliani, Aneel Paulus, Fabio Malavasi
The Circular Life of Human CD38: From Basic Science to Clinics and Back. Molecules (Basel, Switzerland) 25 (20) (2020)
Francesco Lanza, Jerard Seghatchian
Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID-19 infected patients. British journal of haematology 190 (1) (2020)
Francesco Saraceni, Eric Beohou, Myriam Labopin, William Arcese, Francesca Bonifazi, Polina Stepensky, Mahmoud Aljurf, Benedetto Bruno, Pietro Pioltelli, Jakob Passweg, Gerard Sociè, Stella Santarone, Ibrahim Yakoub-Agha, Francesco Lanza, Bipin N Savani, Mohamad Mohty, Arnon Nagler, null null
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia. American journal of hematology 93 (10) (2018)
Francesco Lanza, Francesco Saraceni, Annalisa Pezzi, Massimo Martino, Alberto Bosi, Nicola Cascavilla, Pellegrino Musto, Eliana Zuffa, Monica Tani, Claudia Cellini, Daniele Laszlo, Francesca Bonifazi, null null
A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach. American journal of hematology 92 (9) (2017)
Francesco Lanza, M C Lazzari, P Brambilla, G Di Martino, P Spedini
An unusual association of paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, and diffuse large B-cell non-Hodgkin lymphoma in a Caucasian man. Annals of hematology 95 (9) (2016)